Position in NVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$60,545,951
+$8,499,749 QoQ
Shares Held
386,332
+13.4% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#48
of 1,603 holders
Holding Since
Dec 2021
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Quantinno Capital Management LP holds $2,173,508,170 across 16 Drug Manufacturers - General names. NVS ranks #9 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
547,546 | $656,743,153 | |
| 2 | JNJ |
Johnson & Johnson
|
1,756,229 | $446,029,479 | |
| 3 | ABBV |
AbbVie Inc.
|
1,138,736 | $286,551,527 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,523,212 | $195,732,742 | |
| 5 | AMGN |
Amgen Inc
|
425,632 | $154,129,859 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
722,993 | $91,342,935 | |
| 7 | PFE |
Pfizer Inc
|
2,712,410 | $65,314,832 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,121,564 | $64,624,517 |
All Filings in NVS
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $60,545,951 | 386,332 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $52,046,202 | 340,728 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $41,525,203 | 301,191 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $32,399,323 | 252,646 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $24,050,616 | 198,749 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $17,797,447 | 159,647 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $13,658,042 | 140,356 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $14,192,317 | 123,390 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $11,878,700 | 111,579 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $6,700,196 | 69,267 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $6,240,753 | 61,808 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,841,569 | 57,349 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,993,477 | 19,755 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $1,579,456 | 17,168 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $1,169,743 | 12,894 | Shares | Sole | 2023-02-13 | |
| 2021-12-31 | $259,610 | 2,968 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||